Interested in supporting this program? The SITC Development team would love to work with you. Contact Development@sitcancer.org for more information on how your organization's support can help advance cancer immunotherapy and make "cure" a reality.
Targets for Cancer IO: A Deep Dive Series 4 is supported, in part, by grants from Amgen, Ankyra Therapeutics, and Kite, a Gilead Company.
Contact Development@sitcancer.org for more information on how your organization's support can help advance cancer immunotherapy and make "cure" a reality.
02:02:16